Talphera (NASDAQ:TLPH) CEO Vincent Angotti Buys 105,364 Shares of Stock

Talphera, Inc. (NASDAQ:TLPH) CEO Vincent Angotti purchased 105,364 shares of the business’s stock in a transaction dated Thursday, February 12th. The shares were bought at an average price of $0.81 per share, with a total value of $85,344.84. Following the purchase, the chief executive officer directly owned 586,954 shares of the company’s stock, valued at approximately $475,432.74. The trade was a 21.88% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Talphera Price Performance

Talphera stock opened at $0.78 on Friday. Talphera, Inc. has a 1-year low of $0.38 and a 1-year high of $1.57. The company has a market cap of $36.20 million, a PE ratio of -2.04 and a beta of 0.46. The stock’s 50 day moving average price is $1.00 and its 200 day moving average price is $0.99.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on TLPH shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Talphera in a research report on Wednesday, January 21st. Wall Street Zen raised Talphera to a “hold” rating in a research note on Saturday, November 1st. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $6.00.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Group One Trading LLC boosted its position in shares of Talphera by 3,224.0% in the third quarter. Group One Trading LLC now owns 30,415 shares of the company’s stock valued at $27,000 after acquiring an additional 29,500 shares during the period. Virtu Financial LLC acquired a new position in Talphera during the 3rd quarter valued at $29,000. Persistent Asset Partners Ltd bought a new stake in Talphera in the 4th quarter valued at $42,000. Mariner LLC grew its position in Talphera by 132.0% in the 4th quarter. Mariner LLC now owns 58,000 shares of the company’s stock worth $66,000 after purchasing an additional 33,000 shares during the last quarter. Finally, Dauntless Investment Group LLC bought a new position in shares of Talphera during the 3rd quarter worth about $89,000. 37.67% of the stock is currently owned by institutional investors and hedge funds.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.